Approximately half of all melanoma patients harbor mutations of the proto-oncogene BRAF encoding a serine/threonine protein kinase in the RAS-RAF-MEK-ERK kinase pathway, which in turn promotes cell growth and proliferation (Holderfield et al., 2014). Here, BRAF is linked to melanoma.